Pharmaron Beijing Co., Ltd. (SHE:300759)
China
· Delayed Price · Currency is CNY 27.11
-0.24 (-0.88%)
At close: Mar 9, 2026
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 45.96 billion as of March 9, 2026. Its market cap has increased by 7.20% in one year.
Market Cap
45.96B
Enterprise Value
50.64B
Revenue
13.54B
Ranking
n/a
PE Ratio
31.67
Stock Price
27.11
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 45.96B, an increase of 534.88%. That is a compound annual growth rate of 29.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 43.80B |
| Beijing Wantai Biological Pharmacy Enterprise | 49.56B |
| Shanghai RAAS Blood Products | 41.21B |
| Haisco Pharmaceutical Group | 52.21B |
| Hebei Changshan Biochemical Pharmaceutical | 39.43B |
| Chongqing Zhifei Biological Products | 38.68B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 35.97B |
| Asymchem Laboratories (Tianjin) | 35.00B |